Clinical trial begins in DRC for Ebola treatment
A clinical trial has begun enrolling Ebola patients in the Democratic Republic of the Congo to evaluate potential treatment. The World Health Organization said it will assess an antibody and antiviral drug remdesivir. The chief of the Africa Centers for Disease Control and Prevention warned that the ongoing outbreak remains very serious as the DRC has reported more than 400 deaths.
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.